In addition to CCL3, another chemokine—CCL5, which could be a potential biomarker in human MPS IIIB plasma45, was also significantly upregulated in both Naglu KO mouse CSF and serum (Fig. 5a,c). The gene discussed is CCL5; the disease is mucopolysaccharidosis type 3B.